Search
Free Newsletters
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Editions
Español
Deutsch
Français
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
About
Editions
Español
Deutsch
Français
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
GOOGL
-1.57%
$157.64
-$2.52
TSLA
-3.33%
$282.30
-$9.74
MSFT
-0.92%
$390.43
-$3.62
META
-2.36%
$541.37
-$13.07
AMZN
-2.87%
$182.02
-$5.38
AAPL
-0.39%
$210.38
-$0.83
TRI
+0.10%
$184.48
+$0.18
NVDA
-1.54%
$107.35
-$1.68
FOXA
-0.75%
$49.26
-$0.37
PARA
-0.77%
$11.66
-$0.09
GOOGL
-1.57%
$157.64
-$2.52
TSLA
-3.33%
$282.30
-$9.74
MSFT
-0.92%
$390.43
-$3.62
META
-2.36%
$541.37
-$13.07
AMZN
-2.87%
$182.02
-$5.38
AAPL
-0.39%
$210.38
-$0.83
TRI
+0.10%
$184.48
+$0.18
NVDA
-1.54%
$107.35
-$1.68
FOXA
-0.75%
$49.26
-$0.37
PARA
-0.77%
$11.66
-$0.09
Markets
RECENT NEWS
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
Friday 5:00AM
Cigna is putting a cap on weight loss drug costs
May 22, 2025
Noom is offering smaller doses of compounded Wegovy for weight loss
May 20, 2025
Novo Nordisk's CEO is out after the Ozempic maker's stock dropped 50% in a year
May 16, 2025
Advertisement